Last 7 days
-7.9%
Last 30 days
-11.9%
Last 90 days
-17.5%
Trailing 12 Months
-19.9%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-07 | Khattar Jack A. | sold (taxes) | -539,408 | 32.1 | -16,804 | president, ceo |
2023-09-07 | Bhatt Padmanabh P. | acquired | - | - | 2,500 | sr. vp of ip, cso |
2023-09-07 | Khattar Jack A. | acquired | - | - | 35,000 | president, ceo |
2023-09-07 | Bhatt Padmanabh P. | sold (taxes) | -37,942 | 32.1 | -1,182 | sr. vp of ip, cso |
2023-08-30 | Martin Tami Tillotson | acquired | 194,319 | 23.99 | 8,100 | sr. v.p., regulatory affairs |
2023-08-30 | Martin Tami Tillotson | sold | -259,200 | 32.00 | -8,100 | sr. v.p., regulatory affairs |
2023-08-25 | Martin Tami Tillotson | sold | -162,215 | 31.59 | -5,135 | sr. v.p., regulatory affairs |
2023-05-11 | DEC TIMOTHY C | acquired | - | - | 1,500 | senior vice-president & cfo |
2023-05-11 | Khattar Jack A. | sold (taxes) | -547,232 | 36.47 | -15,005 | president, ceo |
2023-05-11 | Khattar Jack A. | acquired | - | - | 31,250 | president, ceo |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-12 | Farther Finance Advisors, LLC | unchanged | - | -401 | 1,954 | -% |
2023-08-24 | Alberta Investment Management Corp | unchanged | - | -87,256 | 425,109 | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | new | - | 553,104 | 553,104 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.65 | -459,365 | 1,929,820 | -% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 5.89 | -71,000 | 507,000 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 0.86 | -48,777 | 250,101 | -% |
2023-08-18 | Legato Capital Management LLC | unchanged | - | -137,646 | 670,609 | 0.09% |
2023-08-16 | CASTLEARK MANAGEMENT LLC | sold off | -100 | -4,017,180 | - | -% |
2023-08-16 | Nuveen Asset Management, LLC | reduced | -32.48 | -6,802,520 | 8,666,480 | -% |
2023-08-16 | Bridge City Capital, LLC | added | 0.06 | -386,272 | 1,888,610 | 0.89% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | armistice capital, llc | 8.06% | 4,356,000 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 10.71% | 5,789,960 | SC 13G/A | |
Jan 23, 2023 | blackrock inc. | 17.8% | 9,604,073 | SC 13G/A | |
Feb 15, 2022 | armistice capital, llc | 7.8% | 4,136,000 | SC 13G/A | |
Jan 27, 2022 | blackrock inc. | 15.9% | 8,451,022 | SC 13G/A | |
Jan 26, 2022 | blackrock inc. | 15.9% | 8,451,022 | SC 13G/A | |
Feb 16, 2021 | armistice capital, llc | 5.9% | 3,120,000 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 10.06% | 5,298,078 | SC 13G/A | |
Jan 25, 2021 | blackrock inc. | 16.9% | 8,912,801 | SC 13G | |
Mar 12, 2020 | armistice capital, llc | 5.5% | 2,888,000 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 07, 2023 | 4 | Insider Trading | |
Sep 07, 2023 | 4 | Insider Trading | |
Sep 01, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 29, 2023 | 4 | Insider Trading | |
Aug 25, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 25, 2023 | 4 | Insider Trading | |
Aug 25, 2023 | 4 | Insider Trading | |
Aug 21, 2023 | 3 | Insider Trading | |
Aug 21, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
LLY | 512.5B | 29.5B | 3.56% | 89.32% | 78.88 | 17.36 | 1.53% | 14.16% |
JNJ | 423.3B | 97.8B | -2.65% | 0.10% | 32.43 | 4.33 | 2.29% | -28.92% |
MRK | 272.8B | 58.3B | -2.13% | 26.48% | 17.88 | 4.63 | 2.00% | -81.24% |
PFE | 189.8B | 77.9B | -9.16% | -24.26% | 8.84 | 2.44 | -23.04% | -26.74% |
BMY | 150.1B | 45.2B | -5.06% | -15.06% | 23.72 | 3.25 | -4.15% | 20.34% |
MID-CAP | ||||||||
RETA | 6.5B | - | 1.75% | 544.26% | -74.04 | 4.1K | -86.94% | 71.24% |
PRGO | 4.5B | 4.6B | -11.49% | -16.32% | -66.69 | 0.98 | 6.60% | 42.04% |
SMALL-CAP | ||||||||
TLRY | 1.9B | 627.1M | -7.75% | -1.79% | -1.34 | 3.1 | -0.20% | -204.67% |
SUPN | 1.5B | 634.0M | -11.88% | -19.94% | 34.62 | 2.37 | 0.62% | -24.59% |
INVA | 832.3M | 244.3M | -4.13% | 4.68% | 4.22 | 3.41 | -39.50% | -4.99% |
CRON | 830.8M | 109.5M | 21.79% | -27.57% | -5.79 | 7.59 | -2.66% | -32.13% |
CGC | 480.0M | 453.3M | 110.37% | -71.69% | -0.39 | 1.06 | -16.04% | 55.90% |
ACRS | 479.1M | 31.2M | -7.77% | -52.62% | -4.55 | 15.37 | 407.54% | -26.47% |
OCUL | 269.4M | 54.6M | -13.04% | -44.44% | -2.97 | 4.93 | 9.39% | -179.16% |
ENDP | - | 2.2B | - | - | - | - | -22.39% | 63.59% |
15.0%
0.8%
-10.8%
7.4%
95.8%
45.4%
38.1%
Y-axis is the maximum loss one would have experienced if Supernus Pharmaceuticals was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -5.2% | 634 | 668 | 667 | 659 | 630 | 601 | 580 | 564 | 571 | 556 | 520 | 477 | 424 | 402 | 393 | 408 | 409 | 404 | 409 | 381 | 359 |
Costs and Expenses | -0.9% | 614 | 619 | 621 | 641 | 578 | 527 | 494 | 441 | 424 | 398 | 347 | 306 | 269 | 250 | 244 | 261 | 264 | 265 | 264 | 242 | 235 |
S&GA Expenses | -3.7% | 359 | 372 | 377 | 405 | 365 | 334 | 305 | 260 | 242 | 221 | 201 | 179 | 164 | 155 | 153 | 157 | 158 | 159 | 155 | 152 | 152 |
R&D Expenses | 10.7% | 83.00 | 75.00 | 75.00 | 78.00 | 78.00 | 77.00 | 90.00 | 87.00 | 85.00 | 91.00 | 76.00 | 78.00 | 78.00 | 73.00 | 69.00 | 79.00 | 83.00 | 86.00 | 89.00 | 76.00 | 68.00 |
EBITDA | -100.0% | - | 142 | 149 | 96.00 | 114 | 108 | 108 | 131 | 155 | 172 | 189 | 177 | 164 | 160 | 157 | 169 | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.21* | 0.22* | 0.15* | 0.18* | 0.18* | 0.19* | 0.23* | 0.27* | 0.31* | 0.36* | 0.37* | 0.39* | 0.40* | 0.40* | 0.41* | - | - | - | - | - |
Interest Expenses | -43.3% | 1.00 | 2.00 | 3.00 | -9.50 | -5.30 | -1.64 | 3.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 3.00 | 14.00 | 12.00 | 11.00 | 1.00 | 9.00 | 5.00 |
Earnings Before Taxes | -51.7% | 27.00 | 55.00 | 61.00 | 28.00 | 57.00 | 77.00 | 73.00 | 111 | 135 | 151 | 169 | 170 | 157 | 152 | 147 | 145 | 142 | 133 | 140 | 136 | 123 |
EBT Margin | -100.0% | - | 0.08* | 0.09* | 0.04* | 0.09* | 0.13* | 0.13* | 0.20* | 0.24* | 0.27* | 0.32* | 0.36* | 0.37* | 0.38* | 0.38* | 0.36* | - | - | - | - | - |
Net Income | -16.7% | 43.00 | 52.00 | 61.00 | 38.00 | 57.00 | 73.00 | 53.00 | 82.00 | 100 | 111 | 127 | 129 | 118 | 116 | 113 | 106 | 105 | 103 | 111 | 99.00 | 87.00 |
Net Income Margin | -100.0% | - | 0.08* | 0.09* | 0.06* | 0.09* | 0.12* | 0.09* | 0.14* | 0.18* | 0.20* | 0.24* | 0.27* | 0.28* | 0.29* | 0.29* | 0.26* | - | - | - | - | - |
Free Cashflow | -100.0% | - | 161 | - | 138 | 120 | 93.00 | 125 | 108 | 118 | 163 | 135 | 145 | 177 | 114 | 140 | 131 | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -27.8% | 1,293 | 1,792 | 1,703 | 1,693 | 1,695 | 1,640 | 1,689 | 1,555 | 1,573 | 1,507 | 1,504 | 1,510 | 1,491 | 1,190 | 1,160 | 1,107 | 1,064 | 1,025 | 978 | 923 | 853 |
Current Assets | -52.1% | 424 | 883 | 734 | 664 | 625 | 569 | 602 | 668 | 639 | 586 | 630 | 552 | 557 | 557 | 473 | 427 | 391 | 420 | 493 | 391 | 285 |
Cash Equivalents | -57.7% | 25.00 | 58.00 | 93.00 | 111 | 173 | 116 | 203 | 215 | 224 | 256 | 289 | 204 | 211 | 226 | 181 | 117 | 87.00 | 123 | 192 | 124 | 35.00 |
Inventory | -0.6% | 91.00 | 91.00 | 92.00 | 83.00 | 85.00 | 89.00 | 86.00 | 60.00 | 58.00 | 50.00 | 48.00 | 42.00 | 35.00 | 24.00 | 27.00 | 26.00 | 26.00 | 27.00 | 26.00 | 23.00 | 21.00 |
Net PPE | -2.9% | 14.00 | 15.00 | 15.00 | - | - | 17.00 | 17.00 | - | - | 38.00 | 38.00 | 17.00 | 18.00 | 18.00 | 17.00 | 10.00 | 4.00 | 4.00 | 4.00 | 7.00 | 5.00 |
Goodwill | 0% | 117 | 117 | 117 | 117 | 115 | 115 | 118 | 40.00 | 78.00 | 78.00 | 78.00 | 89.00 | 88.00 | - | - | - | - | - | - | - | - |
Liabilities | -57.6% | 373 | 880 | 816 | 840 | 854 | 811 | 873 | 745 | 787 | 753 | 759 | 801 | 825 | 576 | 565 | 550 | 541 | 545 | 525 | 501 | 462 |
Current Liabilities | -65.5% | 253 | 732 | 688 | 726 | 736 | 285 | 315 | 235 | 283 | 241 | 245 | 300 | 269 | 168 | 161 | 150 | 144 | 152 | 161 | 138 | 104 |
LT Debt, Current | - | - | - | - | 401 | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | - | - | - | 379 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 0.9% | 920 | 912 | 886 | 853 | 841 | 828 | 816 | 810 | 786 | 754 | 745 | 709 | 666 | 613 | 595 | 557 | 523 | 480 | 453 | 422 | 390 |
Retained Earnings | -0.2% | 497 | 498 | 481 | 456 | 454 | 446 | 380 | 377 | 356 | 332 | 326 | 296 | 256 | 221 | 200 | 166 | 138 | 105 | 86.00 | 61.00 | 33.00 |
Additional Paid-In Capital | 1.9% | 424 | 416 | 408 | 401 | 390 | 383 | 434 | 429 | 424 | 416 | 409 | 403 | 399 | 392 | 388 | 384 | 379 | 374 | 370 | 365 | 362 |
Shares Outstanding | 0% | 54.00 | 54.00 | 54.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -55.7% | 72.00 | 162 | 117 | 138 | 120 | 95.00 | 127 | 110 | 120 | 166 | 138 | 150 | 182 | 119 | 143 | 132 | 157 | 135 | 129 | 132 | 109 |
Share Based Compensation | 9.0% | 22.00 | 20.00 | 18.00 | 17.00 | 16.00 | 18.00 | 18.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 16.00 | 16.00 | 15.00 | 14.00 | 13.00 | 12.00 | 11.00 | 10.00 | 10.00 |
Cashflow From Investing | 81.6% | 169 | 93.00 | -216 | -91.77 | -15.24 | -80.45 | -81.91 | -108 | -114 | -141 | -34.70 | -64.61 | -61.66 | -19.24 | -157 | -143 | -109 | -465 | -413 | -466 | -513 |
Cashflow From Financing | -524.6% | -389 | 92.00 | -10.48 | -150 | -155 | -154 | -130 | 9.00 | 7.00 | 6.00 | 4.00 | 2.00 | 3.00 | 3.00 | 4.00 | 4.00 | 5.00 | 10.00 | 376 | 376 | 378 |
Condensed Consolidated Statements of Earnings (Loss) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues | ||||
Total revenues | $ 135,563 | $ 170,051 | $ 289,327 | $ 322,557 |
Costs and expenses | ||||
Cost of goods sold | 21,091 | 20,457 | 44,551 | 38,389 |
Research and development | 24,379 | 16,385 | 45,591 | 37,224 |
Selling, general and administrative | 86,782 | 100,476 | 172,379 | 190,935 |
Amortization of intangible assets | 20,108 | 20,644 | 40,074 | 41,288 |
Contingent consideration expense (gain) | 790 | 743 | (857) | 1,408 |
Total costs and expenses | 153,150 | 158,705 | 301,738 | 309,244 |
Operating earnings (loss) | (17,587) | 11,346 | (12,411) | 13,313 |
Other income (expense) | ||||
Interest expense | (910) | (1,810) | (2,415) | (3,752) |
Interest and other income, net | 1,370 | 1,788 | 6,716 | 16,486 |
Total other income (expense) | 460 | (22) | 4,301 | 12,734 |
Earnings (loss) before income taxes | (17,127) | 11,324 | (8,110) | 26,047 |
Income tax expense (benefit) | (16,296) | 3,459 | (24,227) | (7,434) |
Net earnings (loss) | $ (831) | $ 7,865 | $ 16,117 | $ 33,481 |
Earnings (loss) per share | ||||
Basic (in dollars per share) | $ (0.02) | $ 0.15 | $ 0.30 | $ 0.63 |
Diluted (in dollars per share) | $ (0.02) | $ 0.14 | $ 0.29 | $ 0.57 |
Weighted average shares outstanding | ||||
Basic (in shares) | 54,502,993 | 53,426,163 | 54,442,463 | 53,378,319 |
Diluted (in shares) | 54,502,993 | 61,397,159 | 59,035,154 | 61,401,694 |
Net product sales | ||||
Revenues | ||||
Total revenues | $ 128,336 | $ 165,459 | $ 268,911 | $ 312,923 |
Royalty revenues | ||||
Revenues | ||||
Total revenues | $ 7,227 | $ 4,592 | $ 20,416 | $ 9,634 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 24,706 | $ 93,120 |
Marketable securities | 126,950 | 368,214 |
Accounts receivable, net | 136,556 | 165,497 |
Inventories, net | 90,560 | 91,541 |
Prepaid expenses and other current assets | 44,766 | 15,779 |
Total current assets | 423,538 | 734,151 |
Long-term marketable securities | 37,478 | 93,896 |
Property and equipment, net | 14,186 | 15,173 |
Intangible assets, net | 662,389 | 702,463 |
Goodwill | 117,019 | 117,019 |
Other assets | 38,489 | 39,806 |
Total assets | 1,293,099 | 1,702,508 |
Current liabilities | ||
Accounts payable and accrued liabilities | 83,044 | 96,342 |
Accrued product returns and rebates | 148,826 | 151,665 |
Convertible notes, net | 0 | 401,968 |
Contingent consideration, current portion | 20,720 | 21,120 |
Other current liabilities | 0 | 16,863 |
Total current liabilities | 252,590 | 687,958 |
Contingent consideration, long-term | 33,390 | 33,847 |
Operating lease liabilities, long-term | 34,177 | 35,998 |
Deferred income tax liabilities, net | 44,300 | 49,809 |
Other liabilities | 8,734 | 8,692 |
Total liabilities | 373,191 | 816,304 |
Stockholders’ equity | ||
Common stock, $0.001 par value; 130,000,000 shares authorized; 54,592,901 and 54,253,796 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | 55 | 54 |
Additional paid-in capital | 424,266 | 408,115 |
Accumulated other comprehensive loss, net of tax | (1,775) | (3,210) |
Retained earnings | 497,362 | 481,245 |
Total stockholders’ equity | 919,908 | 886,204 |
Total liabilities and stockholders’ equity | $ 1,293,099 | $ 1,702,508 |